Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs Dexmedetomidine for Emergence Agitation in Pediatrics
NCT05273671Phase 4Unknown
- Sponsor
- Alexandria University
- Start
- Mar 2022
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of nalbuphine in Emergence agitation (EA), sponsored by Alexandria University. Status: unknown.
02
Drugs
nalbuphine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT05273671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05273671.